Health
Has the psilocybin therapy industry peaked already in Oregon? Growth is slow, and uncertainty reigns, but safeguards seem to be working.
Entrepreneurs Nick Janicki of the float tank company True REST and Robin Arnott of the “digital psychedelic” company SoundSelf are teaming up to create centers that they say will offer clinical ketamine treatment together with prep and integration services including float tanks, music, and light technologies.
A case report on two patients with multiple sclerosis has sparked hope, caution, and calls to expand the limited research data on ibogaine as a possible treatment for MS.
In the second part of our two-part interview with Dr. Howard Kornfeld, Ann Harrison asks the addiction treatment expert about ketamine dependency.
In the first part of a two-part series, Ann Harrison interviews addiction treatment expert Dr. Howard Kornfeld about the FDA decision to reject the Lykos Therapeutics proposal for MDMA-assisted therapy.
Can post-market surveillance ensure the safety of psychedelic therapies?
A new report shows ER visits and hospitalizations associated with psychedelic use in California are up, but the reasons are unclear.
An all-volunteer corps of over 400 medical professionals organized to help the Tribe of Nova festival survivors begin to heal, with an emphasis on rapid response.
A forthcoming study that examines the impact of psychedelics on religious clergy appears to support earlier findings about the nature and persistence of mystical experiences.
A conversation with the eminent scientist Roland Griffiths about the importance of studying psychedelics and transformative experiences.
